AMBROSINO, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 2.514
EU - Europa 2.450
AS - Asia 939
SA - Sud America 204
AF - Africa 93
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 7
Totale 6.215
Nazione #
US - Stati Uniti d'America 2.450
RU - Federazione Russa 1.297
SG - Singapore 333
IE - Irlanda 311
CN - Cina 281
BR - Brasile 157
IT - Italia 119
DE - Germania 118
FI - Finlandia 93
AT - Austria 87
UA - Ucraina 81
GB - Regno Unito 80
VN - Vietnam 79
SE - Svezia 71
IN - India 64
FR - Francia 62
CI - Costa d'Avorio 60
BE - Belgio 46
HK - Hong Kong 43
CA - Canada 40
PL - Polonia 31
AR - Argentina 21
JP - Giappone 19
BD - Bangladesh 17
MX - Messico 16
ES - Italia 14
IQ - Iraq 14
NL - Olanda 14
ZA - Sudafrica 13
ID - Indonesia 12
IR - Iran 10
TR - Turchia 9
EC - Ecuador 7
LT - Lituania 7
AU - Australia 6
CO - Colombia 6
MY - Malesia 6
PK - Pakistan 6
EU - Europa 5
IL - Israele 5
JO - Giordania 5
KZ - Kazakistan 5
MA - Marocco 5
PH - Filippine 5
CL - Cile 4
KR - Corea 4
PY - Paraguay 4
DO - Repubblica Dominicana 3
GR - Grecia 3
KE - Kenya 3
RS - Serbia 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DZ - Algeria 2
JM - Giamaica 2
KG - Kirghizistan 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
RO - Romania 2
SN - Senegal 2
TN - Tunisia 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BO - Bolivia 1
CR - Costa Rica 1
ET - Etiopia 1
GE - Georgia 1
GF - Guiana Francese 1
GM - Gambi 1
HN - Honduras 1
KW - Kuwait 1
MD - Moldavia 1
ML - Mali 1
MU - Mauritius 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
SV - El Salvador 1
TG - Togo 1
TH - Thailandia 1
TM - Turkmenistan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.215
Città #
Dallas 507
Moscow 425
Dublin 308
San Jose 259
Chandler 240
Jacksonville 171
Singapore 153
Ashburn 123
Beijing 107
New York 95
Ann Arbor 92
Vienna 82
Helsinki 78
Abidjan 60
The Dalles 47
Woodbridge 47
Brussels 46
Wilmington 45
Hong Kong 43
Frankfurt am Main 42
Los Angeles 41
San Mateo 33
Lauterbourg 29
Boardman 28
Princeton 28
Ho Chi Minh City 25
Warsaw 25
Rome 24
Dearborn 22
Chennai 21
São Paulo 20
Orem 19
Tokyo 17
Molise 16
Poplar 15
Hillsboro 14
Houston 14
London 14
Columbus 13
Hanoi 13
Stockholm 12
Toronto 12
Da Nang 11
San Francisco 11
Hefei 10
Montreal 10
Nanjing 10
Johannesburg 9
Kunming 9
Mexico City 9
Naples 9
Redwood City 9
Santa Clara 9
Boston 8
Brooklyn 8
Chicago 8
Mumbai 8
Munich 8
Phoenix 8
Baghdad 7
Jakarta 7
Amsterdam 6
Ankara 6
Augusta 6
Buffalo 6
Council Bluffs 6
Denver 6
Falkenstein 6
Manchester 6
Mountain View 6
Napoli 6
Norwalk 6
Amman 5
Atlanta 5
Calgary 5
Curitiba 5
Lahore 5
Milan 5
New Delhi 5
Nuremberg 5
Ottawa 5
Pune 5
Quito 5
Seattle 5
Wuhan 5
Brasília 4
Buenos Aires 4
City of London 4
Clearwater 4
Porto Alegre 4
Roseto Degli Abruzzi 4
Sacramento 4
Shenyang 4
Zhengzhou 4
Athens 3
Baotou 3
Belgrade 3
Bexley 3
Charlotte 3
Dhaka 3
Totale 3.778
Nome #
Activation of Kv7 potassium channels inhibits intracellular Ca2+ increases triggered by TRPV1-mediated pain-inducing stimuli in F11 immortalized sensory neurons 284
Epilepsy-causing mutations in kv7.2 c-terminus affect binding and functional modulation by calmodulin. 227
Effects of natural and synthetic isothiocyanate-based H2S-releasers against chemotherapy-induced neuropathic pain: Role of Kv7 potassium channels 213
Pharmacological Targeting Of Neuronal Kv7.2/3 Channels: A Focus On Chemotypes And Receptor Sites 211
Characterization of two de novo KCNT1 mutations in children with malignant migrating partial seizures in infancy 210
Molecular pathophysiology and pharmacology of the voltage-sensing module of neuronal ion channels 207
A novel homozygous KCNQ3 loss-of-function variant causes non-syndromic intellectual disability and neonatal-onset pharmacodependent epilepsy 205
Expression and function of Kv7.4 channels in Rat cardiac mitochondria: possible targets for cardioprotection 203
Early-Onset Epileptic Encephalopathy Caused by Gain-of-Function Mutations in the Voltage Sensor of Kv7.2 and Kv7.3 Potassium Channel Subunits. 201
Epileptic encephalopathy in a patientwith a novel variant in the Kv7.2 S2 transmembrane segment: Clinical, genetic, and functional features 200
Early-onset epileptic encephalopathy caused by a reduced sensitivity of Kv7.2 potassium channels to phosphatidylinositol 4,5-bisphosphate 197
Differential Regulation of PI(4,5)P2Sensitivity of Kv7.2 and Kv7.3 Channels by Calmodulin 197
Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy 197
De novo gain-of-function variants in KCNT2 as a novel cause of developmental and epileptic encephalopathy 190
Calcium cytotoxicity sensitizes prostate cancer cells to standard-of-care treatments for locally advanced tumors 179
Identification of a Potent Tryptophan-Based TRPM8 Antagonist with in Vivo Analgesic Activity 178
Infantile spasms and encephalopathy without preceding neonatal seizures caused by KCNQ2 R198Q, a gain-of-function variant 177
β-Adrenergic response is counteracted by extremely-low-frequency pulsed electromagnetic fields in beating cardiomyocytes 164
Kv7.3 Compound Heterozygous Variants in Early Onset Encephalopathy Reveal Additive Contribution of C-Terminal Residues to PIP2-Dependent K+Channel Gating 161
Neutralization of a unique, negatively-charged residue in the voltage sensor of K(V)7.2 subunits in a sporadic case of benign familial neonatal seizures 160
Neuronal potassium channel openers in the management of epilepsy: role and potential of retigabine 160
A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: "Precision medicine" approach with fluoxetine 159
KCNQ2 R144 variants cause neurodevelopmental disability with language impairment and autistic features without neonatal seizures through a gain-of-function mechanism 158
Tryptamine-Based Derivatives as Transient Receptor Potential Melastatin Type 8 (TRPM8) Channel Modulators 152
Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy 152
Erratum to: Towards the realization of label-free biosensors through impedance spectroscopy integrated with IDES technology 152
Kv7.4 channels regulate potassium permeability in neuronal mitochondria 148
Epileptic channelopathies caused by neuronal Kv7 (KCNQ) channel dysfunction 143
Functional Characterization of Two Variants at the Intron 6-Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes 141
De novo variants in KCNA3 cause developmental and epileptic encephalopathy 137
Gain of function due to increased opening probability by two KCNQ5 pore variants causing developmental and epileptic encephalopathy 132
Case report: Marked electroclinical improvement by fluoxetine treatment in a patient with KCNT1-related drug-resistant focal epilepsy 130
Fluoxetine Treatment in Epilepsy of Infancy with Migrating Focal Seizures Due to KCNT1 Variants: An Open Label Study. 122
In Silico Assisted Identification, Synthesis, and In Vitro Pharmacological Characterization of Potent and Selective Blockers of the Epilepsy-Associated KCNT1 Channel 112
KCNT2-Related Disorders: Phenotypes, Functional, and Pharmacological Properties 103
Synthesis and Pharmacological Characterization of Conformationally Restricted Retigabine Analogues as Novel Neuronal Kv7 Channel Activators 103
Long-Term Survival of Methotrexate as First-Line Therapy in Rheumatoid Arthritis, Psoriatic Arthritis and Undifferentiated Arthritis 83
Pharmacological approaches in drug-resistant pediatric epilepsies caused by pathogenic variants in potassium channel genes. 82
Totale 6.330
Categoria #
all - tutte 24.710
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.710


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 0 0 4
2021/2022209 4 29 1 8 22 14 7 18 42 26 22 16
2022/2023886 116 50 6 101 65 78 1 37 377 31 18 6
2023/2024220 36 27 9 3 5 68 5 6 10 5 7 39
2024/2025700 67 20 93 26 149 18 36 24 81 16 75 95
2025/20263.385 107 328 349 267 919 613 235 109 116 262 54 26
Totale 6.330